2nd Quarter - Report

WINNING STRATEGIES WASHINGTON for NOVARTIS

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$40,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 20, 2012 $40,000 Replaced
2nd Quarter - Amendment Oct 4, 2012 $40,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY13 Department of Defense Appropriations Orphan drugs and tax issues PDUFA

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
MICHAEL A MEROLA —
DONNA MULLINS —
ROBERT ZUCKER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Patient Protection and Innovative Biologic Medicines Act of 2009 Implementation of health care reform Implementation and progress of the deficit reduction committee

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
MICHAEL A MEROLA —
DONNA MULLINS —
ROBERT ZUCKER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.